These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies]. Bieck PR. Psychiatr Prax; 1989 Aug; 16 Suppl 1():25-31. PubMed ID: 2587674 [Abstract] [Full Text] [Related]
8. Monoamine oxidase inhibitors: should they be discontinued preoperatively? el-Ganzouri AR, Ivankovich AD, Braverman B, McCarthy R. Anesth Analg; 1985 Jun; 64(6):592-6. PubMed ID: 4003777 [Abstract] [Full Text] [Related]
9. [Comparison of the new MAO-A inhibitors moclobemide, brofaromine and toloxatone with tranylcypromine in an animal experiment: significance for clinical practice]. Da Prada M, Keller HH, Kettler R. Psychiatr Prax; 1989 Aug; 16 Suppl 1():18-24. PubMed ID: 2587673 [Abstract] [Full Text] [Related]
11. Antidepressant treatment with MAO-inhibitors during general and regional anesthesia: a review and case report of spinal anesthesia for lower extremity surgery without discontinuation of tranylcypromine. Krings-Ernst I, Ulrich S, Adli M. Int J Clin Pharmacol Ther; 2013 Oct 25; 51(10):763-70. PubMed ID: 23993253 [Abstract] [Full Text] [Related]
13. Pseudohallucinations associated with moclobemide: a case report. Degner D, Kropp S, Porzig J, Grohmann R, Rüther E. Pharmacopsychiatry; 2005 Jul 04; 38(4):179-81. PubMed ID: 16025422 [Abstract] [Full Text] [Related]
14. Double-blind comparison of moclobemide and tranylcypromine in depression. Heinze G, Rossel L, Gabelic I, Galeano-Munoz J, Stabl M, Allen SR. Pharmacopsychiatry; 1993 Nov 04; 26(6):240-5. PubMed ID: 8127928 [Abstract] [Full Text] [Related]
16. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors. Kennedy SH. J Psychiatry Neurosci; 1997 Mar 04; 22(2):127-31. PubMed ID: 9074307 [Abstract] [Full Text] [Related]